Movement Alert｜DaVita HealthCare Partners Rises 5.15% in Regular Trading, Earnings Preview Supports Sentiment

Market Focus10-29

On October 29, DaVita HealthCare Partners rose 5.15% in Regular Trading, trading at $193.875/share, with turnover of $82.7015 million.

The move aligned with a same-day earnings-preview catalyst: market expectations called for quarterly revenue of $3.508 billion, up 2.31% year over year, and adjusted EPS of $3.61, up 11.90%, reinforcing expectations for modest top-line growth and resilient profitability.

Supporting context was constructive. In the prior quarter, DaVita HealthCare Partners reported adjusted EPS of $4.02 on revenue of $3.554 billion, both above consensus, while management guided full-year adjusted EPS to $14.10-$15.20. Separately, its August value-based kidney care agreement with Humana expanded services for Medicare Advantage members with chronic kidney disease, adding to longer-term business expectations.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment